Suchergebnisse - "Hu, Yongzhou"

PubPharm (10)

1

Synthesis and biological evaluation of novel pyrimido[4,5-b]quinoline-2,4- dione derivatives as MDM2 ubiquitin ligase inhibitors

enthalten in: Medicinal chemistry (Shariqah (United Arab Emirates)) | 2013

von Dou, X. | Li, X. | Tao, L. | +5

2

Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 1

enthalten in: Bioorganic & medicinal chemistry | 2013

von Wang, W. | Shangguan, S. | Qiu, N. | +3

3

Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 2

enthalten in: Bioorganic & medicinal chemistry | 2013

von Wang, W. | Lv, D. | Qiu, N. | +3

4

Small molecule agents targeting the p53-MDM2 pathway for cancer therapy

enthalten in: Medicinal research reviews | 2012

von Wang, W. | Hu, Y.

5

Imidazoline derivatives : a patent review (2006--present)

enthalten in: Expert opinion on therapeutic patents | 2012

von Guan, X. | Hu, Y.

6

QSAR models for isoindolinone-based p53-MDM2 interaction inhibitors using linear and non-linear statistical methods

enthalten in: Chemical biology & drug design | 2012

von Dong, X. | Yan, J. | Lu, D. | +5

7

Design, synthesis and CoMFA studies of N1-amino acid substituted 2,4,5-triphenyl imidazoline derivatives as p53-MDM2 binding inhibitors

enthalten in: Bioorganic & medicinal chemistry | 2012

von Hu, C. | Dou, X. | Wu, Y. | +2

8

Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells

enthalten in: Investigational new drugs | 2012

von Zhang, L. | Yan, Y. | Zhu, D. | +5

9

Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors

enthalten in: Bioorganic & medicinal chemistry | 2011

von Hu, C. | Li, X. | Wang, W. | +6

10

Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2 interaction

enthalten in: Anti-cancer drugs | 2009

von Zhang, L. | Zhang, J. | Hu, C. | +5

1
[1]